OxyContin maker bows out of meeting on harder-to-abuse drug
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.
Jun 30, 2015
1
12
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.
Jun 30, 2015
1
12
A new finger prick rapid Ebola test co-developed by Tulane University researchers is as accurate as traditional lab testing for the disease, according to an independent study published in the British medical journal The Lancet.Â
Jun 29, 2015
0
10
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.
Jun 25, 2015
0
23
Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. ...
Jun 23, 2015
2
329
House Republicans are pushing to ease proposed government regulations for companies that sell e-cigarettes and other new tobacco products, a move that Democrats charge could lead to unsafe products on the market.
Jun 19, 2015
0
9
Artificial trans fats found in everything from margarine to cookies and frozen pizzas are not safe to eat and must be removed from food in the next three years, US regulators said Tuesday.
Jun 16, 2015
1
17
Following a decade of steady growth, use of bisphosphonates—medications that are effective for treating osteoporosis—declined in the United States by more than 50% from 2008 to 2012.
Jun 15, 2015
0
4
The decision this week by experts at the Food and Drug Administration to endorse a pair of medicines aimed at combating heart disease brought on the latest round of hand-wringing over prescription drug costs.
Jun 15, 2015
1
12
Federal health advisers said Wednesday that a highly-anticipated cholesterol-lowering drug from Amgen Inc. should be approved for patients with dangerously high levels of the artery-clogging substance.
Jun 10, 2015
0
3